Voglibose

Strengths: 0.2 mg, 0.3 mg

Dosage Form: Tablets

Description:

Voglibose is an alpha-glucosidase inhibitor that delays the absorption of glucose in the intestine, helping to reduce postprandial blood sugar spikes in type 2 diabetes.

Key Features:

o   Targets post-meal glucose rise

o   Suitable as monotherapy or add-on

o   Low risk of hypoglycemia

Precautions:

Use with caution in patients with gastrointestinal disorders. Should be taken with the first bite of a meal.